Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

HEXO (TSX:HEXO)(NASDAQ:HEXO) is one of the largest licensed cannabis companies in Canada. It’s okay to be bullish on the Canadian cannabis industry, but HEXO stock is not for cautious investors.

The promise of wealth in the marijuana market was fully realized just a few years ago. But after this came the COVID-19 pandemic, supply chain issues, and the disappointing rollout of Cannabis 2.0 (edibles, vapes, etc.). Among the cannabis stocks hardest hit during the decline of the cannabis industry was HEXO, a once-promising competitor in the market.

HEXO shares, valued at around $7 a year ago, can’t even stay above $1 lately. Not so long ago, the stock hovered around $0.26.

Meanwhile, HEXO’s market capitalization fell below $100 million.

Delisting may be a possibility, as the Nasdaq stock exchange has occasionally issued delisting warnings when stocks trade below $1 for an extended period.

HEXO reports huge losses

Meanwhile, HEXO’s financial results are in shambles. During the company’s last quarter, Hexo suffered a net loss of approximately $146.6 million. That figure was around $21 million a year earlier.

The cannabis producer said third-quarter revenue rose 101% to $45.6 million from a year earlier but fell by 14% compared to the previous quarter in a context of continued competition in the Canadian market.

HEXO reported adjusted EBITDA of $18.4 million — a sharp decline from the $10.8 million loss reported in the prior-year quarter.

Clearly, HEXO is not on the right fiscal path. We can ask ourselves if the company is doing what it takes to get out of this financial misery.

To help answer this crucial question, we can check out what HEXO has been up to lately.

HEXO said its restructuring plan to streamline its structure and cut costs included cutting 450 jobs.

In financial documents, the Quebec company indicated that this staff reduction would result in annual savings of $30.6 million and aims to simplify its organizational structure so that costs are more closely aligned with the business’s size.

The company’s latest management discussion and analysis document indicates that most of the reductions will be achieved with less reliance on external consultants, a new information technology platform, and synergies discovered through recent acquisitions.

HEXO will close a processing and manufacturing facility in Belleville, Ontario by the end of July.

Unfortunately, approximately 230 employees will lose their jobs at this factory.

So, what else did HEXO do? Of course, the company is launching a stock market program that will allow HEXO to issue and sell up to $40 million (or the equivalent in Canadian currency) of stock. The obvious concern here is stock dilution.

What to do with HEXO stock

Overall, HEXO is in dire financial straits, and issuing stock is unlikely to be an effective long-term solution. Ultimately, HEXO will have to prove its viability as a business. The road to recovery, if it actually happens, will not be easy.

As HEXO stock could continue its incessant fall, potential investors should simply avoid it altogether and look for a better risk/reward profile elsewhere.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf owns shares of HEXO Corp. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »